IGF-1 LR3 is a synthetic, laboratory-engineered analog of IGF-1 used in controlled research to study receptor interaction, peptide stability, and downstream signaling behavior in experimental systems
Key mechanisms of action include: Fibroblast activation Suppression of collagen-degrading enzymes Reduced inflammatory cytokines Enhanced granulation tissue formation Improved angiogenesis In ischemic wound models, injectable GHK-Cu restored fibroblast function and significantly accelerated skin repair compared to controls
there is the potential for: Ischemic injury due to potent vasoconstrictor action and tissue hypoxia Mild bradycardia, probably as a reflex result of a rise in blood pressure Arrhythmias Anxiety Transient headache Respiratory difficulty Pharmacokinetics: When released from nerve terminals, its actions are primarily (75%) terminated by neuronal reuptake Diffusion and degredation by extracellualr COMT contribute to a lesser extent
The antioxidant components of the MDsuch as polyphenols, vitamins C and A, -carotene, folate, and dietary fibermay enhance reproductive tract antioxidant status, counteract oxidative stress, and protect against reactive oxygen species-related damage, thereby supporting fertility
Hyperpigmentation: 4% niacinamide reduces melasma severity, and 5% formulations show tone improvement when paired with antioxidants and tranexamic acid
